Trimetazidine

This classification denotes a cardiotonic agent with the molecular formula C14H22N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N9A0A0R9S8, chemically known as 1-(2,3,4-trimethoxybenzyl)piperazine but generally known as trimetazidine, which bears US NIH Compound Identifier 21109. European Medicines Agency schedules Trimetazidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11306MIG. The term TRIMETAZIDINE is an International Non-Proprietary Name. World Health Organization schedules trimetazidine in its Anatomical Therapeutic Chemical (ATC) Classification. TRIMETAZIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trimetazidine under HS 29335995 and SITC 51576. As of Q4 2014, TRIMETAZIDINE remains the US FDA Preferred Term for this commodity. Trimetazidine bears US NLM identifiers UMLS ID C0041037 and NCI Concept Code C76590. SMILES: O(C1C(CN2CCNCC2)CCC(OC)C1OC)C.